Dyne Therapeutics, Inc. - COMMON STOCK (DYN)

CUSIP: 26818M108

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
164,064,426
Total 13F shares
121,788,688
Share change
+10,081,867
Total reported value
$1,284,331,056
Put/Call ratio
21%
Price per share
$10.46
Number of holders
202
Value change
-$75,923,327
Number of buys
126
Number of sells
87

Quarterly Holders Quick Answers

What is CUSIP 26818M108?
CUSIP 26818M108 identifies DYN - Dyne Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q1 2025

As of 31 Mar 2025, Dyne Therapeutics, Inc. - COMMON STOCK (DYN) was held by 202 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,788,688 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, BlackRock, Inc., VANGUARD GROUP INC, FCPM III SERVICES B.V., FMR LLC, BRAIDWELL LP, STATE STREET CORP, and CITADEL ADVISORS LLC. This page lists 202 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.